Refreshing results…
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
Download from aacrjournals.orgStatistical power considerations in genotype-based recall randomized controlled trials
Download from www.nature.comMissing publications? Search for publications with a matching author name.